Eton Pharmaceuticals Inc. (ETON) Misses Q4 EPS by 2c

Eton Pharmaceuticals Inc. (NASDAQ: ETON) reported Q4 EPS of ($0.02), $0.02 worse than the analyst estimate of $0.00. Revenue for the quarter came in at $11.65 million versus the consensus estimate of $10.8 million.

For earnings history and earnings-related data on Eton Pharmaceuticals Inc. (ETON) click here.

You May Also Be Interested In

• UBS Starts Kalyan Jewellers India Ltd (KALYANKJ:IN) at Buy
• BetterLife Pharma files final prospectus for $100M public offering
• Micron offers Taiwan workers up to 68-month bonuses as strike threat looms